Deletion of pancreatic β-cell adenosine kinase improves glucose homeostasis in young mice and ameliorates streptozotocin-induced hyperglycaemia

Makawi Ahmed Abdalhamid Osman, Yu Jing Sun, Rui Jia Li, Hui Lin, Dong Mei Zeng, Xin Yu Chen, Dongfang He, Hui Wei Feng, Zhao Yang, Jin Wang, Chaodong Wu, Min Cui, Jin Peng Sun, Yuqing Huo, Xiao Yu

Research output: Contribution to journalArticle

Abstract

Severe reduction in the β-cell number (collectively known as the β-cell mass) contributes to the development of both type 1 and type 2 diabetes. Recent pharmacological studies have suggested that increased pancreatic β-cell proliferation could be due to specific inhibition of adenosine kinase (ADK). However, genetic evidence for the function of pancreatic β-cell ADK under physiological conditions or in a pathological context is still lacking. In this study, we crossed mice carrying LoxP-flanked Adk gene with Ins2-Cre mice to acquire pancreatic β -cell ADK deficiency (Ins2-Cre±Adkfl/fl) mice. Our results revealed that Ins2-Cre+/-Adkfl/fl mice showed improved glucose metabolism and β-cell mass in younger mice, but showed normal activity in adult mice. Moreover, Ins2-Cre±Adkfl/fl mice were more resistant to streptozotocin (STZ) induced hyperglycaemia and pancreatic β-cell damage in adult mice. In conclusion, we found that ADK negatively regulates β-cell replication in young mice as well as under pathological conditions, such as STZ induced pancreatic β-cell damage. Our study provided genetic evidence that specific inhibition of pancreatic β-cell ADK has potential for anti-diabetic therapy.

Original languageEnglish (US)
Pages (from-to)4653-4665
Number of pages13
JournalJournal of Cellular and Molecular Medicine
Volume23
Issue number7
DOIs
StatePublished - Jul 1 2019

Fingerprint

Adenosine Kinase
Streptozocin
Hyperglycemia
Homeostasis
Glucose
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Cell Count
Cell Proliferation
Pharmacology

Keywords

  • adenosine kinase
  • diabetes
  • insulin
  • replication
  • β cell

ASJC Scopus subject areas

  • Molecular Medicine
  • Cell Biology

Cite this

Deletion of pancreatic β-cell adenosine kinase improves glucose homeostasis in young mice and ameliorates streptozotocin-induced hyperglycaemia. / Ahmed Abdalhamid Osman, Makawi; Sun, Yu Jing; Li, Rui Jia; Lin, Hui; Zeng, Dong Mei; Chen, Xin Yu; He, Dongfang; Feng, Hui Wei; Yang, Zhao; Wang, Jin; Wu, Chaodong; Cui, Min; Sun, Jin Peng; Huo, Yuqing; Yu, Xiao.

In: Journal of Cellular and Molecular Medicine, Vol. 23, No. 7, 01.07.2019, p. 4653-4665.

Research output: Contribution to journalArticle

Ahmed Abdalhamid Osman, M, Sun, YJ, Li, RJ, Lin, H, Zeng, DM, Chen, XY, He, D, Feng, HW, Yang, Z, Wang, J, Wu, C, Cui, M, Sun, JP, Huo, Y & Yu, X 2019, 'Deletion of pancreatic β-cell adenosine kinase improves glucose homeostasis in young mice and ameliorates streptozotocin-induced hyperglycaemia', Journal of Cellular and Molecular Medicine, vol. 23, no. 7, pp. 4653-4665. https://doi.org/10.1111/jcmm.14216
Ahmed Abdalhamid Osman, Makawi ; Sun, Yu Jing ; Li, Rui Jia ; Lin, Hui ; Zeng, Dong Mei ; Chen, Xin Yu ; He, Dongfang ; Feng, Hui Wei ; Yang, Zhao ; Wang, Jin ; Wu, Chaodong ; Cui, Min ; Sun, Jin Peng ; Huo, Yuqing ; Yu, Xiao. / Deletion of pancreatic β-cell adenosine kinase improves glucose homeostasis in young mice and ameliorates streptozotocin-induced hyperglycaemia. In: Journal of Cellular and Molecular Medicine. 2019 ; Vol. 23, No. 7. pp. 4653-4665.
@article{4394a1c08baf4fea9e8bae2c7884512c,
title = "Deletion of pancreatic β-cell adenosine kinase improves glucose homeostasis in young mice and ameliorates streptozotocin-induced hyperglycaemia",
abstract = "Severe reduction in the β-cell number (collectively known as the β-cell mass) contributes to the development of both type 1 and type 2 diabetes. Recent pharmacological studies have suggested that increased pancreatic β-cell proliferation could be due to specific inhibition of adenosine kinase (ADK). However, genetic evidence for the function of pancreatic β-cell ADK under physiological conditions or in a pathological context is still lacking. In this study, we crossed mice carrying LoxP-flanked Adk gene with Ins2-Cre mice to acquire pancreatic β -cell ADK deficiency (Ins2-Cre±Adkfl/fl) mice. Our results revealed that Ins2-Cre+/-Adkfl/fl mice showed improved glucose metabolism and β-cell mass in younger mice, but showed normal activity in adult mice. Moreover, Ins2-Cre±Adkfl/fl mice were more resistant to streptozotocin (STZ) induced hyperglycaemia and pancreatic β-cell damage in adult mice. In conclusion, we found that ADK negatively regulates β-cell replication in young mice as well as under pathological conditions, such as STZ induced pancreatic β-cell damage. Our study provided genetic evidence that specific inhibition of pancreatic β-cell ADK has potential for anti-diabetic therapy.",
keywords = "adenosine kinase, diabetes, insulin, replication, β cell",
author = "{Ahmed Abdalhamid Osman}, Makawi and Sun, {Yu Jing} and Li, {Rui Jia} and Hui Lin and Zeng, {Dong Mei} and Chen, {Xin Yu} and Dongfang He and Feng, {Hui Wei} and Zhao Yang and Jin Wang and Chaodong Wu and Min Cui and Sun, {Jin Peng} and Yuqing Huo and Xiao Yu",
year = "2019",
month = "7",
day = "1",
doi = "10.1111/jcmm.14216",
language = "English (US)",
volume = "23",
pages = "4653--4665",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Deletion of pancreatic β-cell adenosine kinase improves glucose homeostasis in young mice and ameliorates streptozotocin-induced hyperglycaemia

AU - Ahmed Abdalhamid Osman, Makawi

AU - Sun, Yu Jing

AU - Li, Rui Jia

AU - Lin, Hui

AU - Zeng, Dong Mei

AU - Chen, Xin Yu

AU - He, Dongfang

AU - Feng, Hui Wei

AU - Yang, Zhao

AU - Wang, Jin

AU - Wu, Chaodong

AU - Cui, Min

AU - Sun, Jin Peng

AU - Huo, Yuqing

AU - Yu, Xiao

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Severe reduction in the β-cell number (collectively known as the β-cell mass) contributes to the development of both type 1 and type 2 diabetes. Recent pharmacological studies have suggested that increased pancreatic β-cell proliferation could be due to specific inhibition of adenosine kinase (ADK). However, genetic evidence for the function of pancreatic β-cell ADK under physiological conditions or in a pathological context is still lacking. In this study, we crossed mice carrying LoxP-flanked Adk gene with Ins2-Cre mice to acquire pancreatic β -cell ADK deficiency (Ins2-Cre±Adkfl/fl) mice. Our results revealed that Ins2-Cre+/-Adkfl/fl mice showed improved glucose metabolism and β-cell mass in younger mice, but showed normal activity in adult mice. Moreover, Ins2-Cre±Adkfl/fl mice were more resistant to streptozotocin (STZ) induced hyperglycaemia and pancreatic β-cell damage in adult mice. In conclusion, we found that ADK negatively regulates β-cell replication in young mice as well as under pathological conditions, such as STZ induced pancreatic β-cell damage. Our study provided genetic evidence that specific inhibition of pancreatic β-cell ADK has potential for anti-diabetic therapy.

AB - Severe reduction in the β-cell number (collectively known as the β-cell mass) contributes to the development of both type 1 and type 2 diabetes. Recent pharmacological studies have suggested that increased pancreatic β-cell proliferation could be due to specific inhibition of adenosine kinase (ADK). However, genetic evidence for the function of pancreatic β-cell ADK under physiological conditions or in a pathological context is still lacking. In this study, we crossed mice carrying LoxP-flanked Adk gene with Ins2-Cre mice to acquire pancreatic β -cell ADK deficiency (Ins2-Cre±Adkfl/fl) mice. Our results revealed that Ins2-Cre+/-Adkfl/fl mice showed improved glucose metabolism and β-cell mass in younger mice, but showed normal activity in adult mice. Moreover, Ins2-Cre±Adkfl/fl mice were more resistant to streptozotocin (STZ) induced hyperglycaemia and pancreatic β-cell damage in adult mice. In conclusion, we found that ADK negatively regulates β-cell replication in young mice as well as under pathological conditions, such as STZ induced pancreatic β-cell damage. Our study provided genetic evidence that specific inhibition of pancreatic β-cell ADK has potential for anti-diabetic therapy.

KW - adenosine kinase

KW - diabetes

KW - insulin

KW - replication

KW - β cell

UR - http://www.scopus.com/inward/record.url?scp=85068268158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068268158&partnerID=8YFLogxK

U2 - 10.1111/jcmm.14216

DO - 10.1111/jcmm.14216

M3 - Article

VL - 23

SP - 4653

EP - 4665

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 7

ER -